Abstract:Factor-based induced reprogramming approaches have tremendous potential for human regenerative medicine, but the efficiencies of these approaches are still low. In this study, we analyzed the global transcriptional profiles of mouse induced pluripotent stem cells (miPSCs) and mouse embryonic stem cells (mESCs) from seven different labs and present here the first successful clustering according to cell type, not by lab of origin. We identified 2131 different expression genes (DEs) as candidate pluripotency-associated genes by comparing mESCs/miPSCs with somatic cells and 720 DEs between miPSCs and mESCs. Interestingly, there was a significant overlap between the two DE sets. Therefore, we defined the overlap DEs as “consensus DEs” including 313 miPSC-specific genes expressed at a higher level in miPSCs versus mESCs and 184 mESC-specific genes in total and reasoned that these may contribute to the differences in pluripotency between mESCs and miPSCs. A classification of “consensus DEs” according to their different expression levels between somatic cells and mESCs/miPSCs shows that 86% of the miPSC-specific genes are more highly expressed in somatic cells, while 73% of mESC-specific genes are highly expressed in mESCs/miPSCs, indicating that the miPSCs have not efficiently silenced the expression pattern of the somatic cells from which they are derived and failed to completely induce the genes with high expression levels in mESCs. We further revealed a strong correlation between oocyte-enriched factors and insufficiently induced mESC-specific genes and identified 11 hub genes via network analysis. In light of these findings, we postulated that these key hub genes might not only drive somatic cell nuclear transfer (SCNT) reprogramming but also augment the efficiency and quality of miPSC reprogramming.

Defining Essential Enhancers for Pluripotent Stem Cells Using a Features-Oriented CRISPR-Cas9 Screen

Enhancing Pluripotency and Lineage Specification

Genome-Wide CRISPR Screen Identifies Puf60 As a Novel Stemness Gene of Mouse Embryonic Stem Cells

A Genome-Wide CRISPR Screen Identifies Factors Regulating Pluripotency Exit in Mouse Embryonic Stem Cells

Dynamic network-guided CRISPRi screen identifies CTCF-loop-constrained nonlinear enhancer gene regulatory activity during cell state transitions

Discovery of enhancers and their essential roles in self-renewal and differentiation in human embryonic stem cells

Inducible CRISPRa screen identifies putative enhancers

A multi-omics integrative analysis based on CRISPR screens re-defines the pluripotency regulatory network in ESCs

Enhancers and super-enhancers have an equivalent regulatory role in embryonic stem cells through regulation of single or multiple genes

Global identification of transcriptional regulators of pluripotency and differentiation in embryonic stem cells.

Genome-wide CRISPR interference screen identifies long non-coding RNA loci required for differentiation and pluripotency

A New Class of Temporarily Phenotypic Enhancers Identified by CRISPR/Cas9-mediated Genetic Screening.

Genome-wide gain-of-function screen identifies novel regulators of pluripotency.

Induce Pluripotency Via Specific Distal Enhancer-Promoter Associations

The Transcription Factor TFCP2L1 Induces Expression of Distinct Target Genes and Promotes Self-Renewal of Mouse and Human Embryonic Stem Cells.

Identifying Candidate Reprogramming Genes in Mouse Induced Pluripotent Stem Cells

Functional Dissection of the Enhancer Repertoire in Human Embryonic Stem Cells

Deciphering Essential Cistromes Using Genome-Wide CRISPR Screens.

A CRISPR/Cas9 screen in embryonic stem cells reveals that Mdm2 regulates totipotency exit

Use of genome-wide RNAi screens to identify regulators of embryonic stem cell pluripotency and self-renewal.

CRISPR Activation Screens Systematically Identify Factors that Drive Neuronal Fate and Reprogramming